Trends and Finance

Former COO of COVID-19 test distributor sentenced for wire fraud

By LabPulse.com staff writers

The former chief operating officer (COO) of a COVID-19 testing kit distributor was sentenced to more than six years in federal prison for embezzling more than $1.85 million in company funds.

September 6, 2024

BillionToOne secures $140M financing agreement with Oberland Capital

By LabPulse.com staff writers

Molecular diagnostics firm BillionToOne has signed a $140 million nondilutive financing agreement with Oberland Capital Management.

September 5, 2024

European Court rules for Illumina in jurisdictional appeal

By LabPulse.com staff writers

The European Court of Justice ruled that the European Commission did not have jurisdiction over Illumina's acquisition of Grail, reversing a ruling by a lower court that dismissed Illumina's appeal and overturning a €432 million ($477.8 million) fine.

September 4, 2024

Hitachi High-Tech, Gencurix forge agreement on cancer diagnostics

By LabPulse.com staff writers

Hitachi High-Tech and oncology molecular diagnostics firm Gencurix have formed a strategic partnership aimed at developing cancer diagnostics and testing services.

August 30, 2024

EDX, Caris sign molecular profiling distribution agreement

By LabPulse.com staff writers

Digital diagnostics developer EDX Medical Group and precision medicine company Caris Life Sciences have signed a distribution agreement for Caris' molecular profiling services.

September 3, 2024

BioMarin to lay off 225 employees, reorganize programs

By LabPulse.com staff writers

BioMarin Pharmaceutical will lay off 225 employees as part of a reorganization, according to a regulatory form the company filed with the U.S. Securities and Exchange Commission.

August 30, 2024

Qiagen ventures into chronic disease CDx

By LabPulse.com staff writers

Qiagen has expanded its agreement with AstraZeneca beyond oncology.

August 29, 2024

Trudell Medical to acquire Vyaire Medical's RDx unit

By LabPulse.com staff writers

Medical device developer Trudell Medical has reached an agreement to buy the respiratory diagnostics (RDx) business of Vyaire Medical.

August 27, 2024

Tome Biosciences to scale back operations, lay off 131 employees

By LabPulse.com staff writers

Biotech firm Tome Biosciences has cut back its operations and will lay off 131 employees, according to an August 22 notice filed with the state of Massachusetts.

August 26, 2024

PreciseDx raises $20.7M in series B funding

By LabPulse.com staff writers

Oncology diagnostics developer PreciseDx has raised $20.7 million in series B funding, bringing its total funding to date to $31.5 million.

August 22, 2024

Johnson & Johnson to acquire V-Wave for up to $1.7B

By LabPulse.com staff writers

Johnson & Johnson has entered a definitive agreement to buy V-Wave, a developer of cardiovascular implant technology.

August 20, 2024

Danaher acquires Genedata

By LabPulse.com staff writers

The Basel, Switzerland-based Genedata, which develops software for biopharmaceutical and biotech R&D, said that it is joining Danaher's life sciences segment.

August 19, 2024

Page 1 of 138

Next Page